Education
About Us
Working with TipRanks
Follow Us
Alzamend Neuro (ALZN)
NASDAQ:ALZN
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -50.74K | $ -50.74K | $ -23.07K | $ 0.00 | $ 0.00 |
| Operating Income | $ -4.50M | $ -9.94M | $ -14.87M | $ -12.32M | $ -4.95M |
| EBITDA | $ -4.45M | $ -9.89M | $ -14.85M | $ -12.32M | $ -4.95M |
| Net Income | $ -4.51M | $ -9.95M | $ -14.88M | $ -12.36M | $ -5.05M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 3.95M | $ 376.05K | $ 5.14M | $ 14.06M | $ 1.93M |
| Total Assets | $ 4.60M | $ 631.59K | $ 5.92M | $ 14.52M | $ 2.91M |
| Total Debt | $ 0.00 | $ 300.71K | $ 0.00 | $ 0.00 | $ 335.30K |
| Net Debt | $ -3.95M | $ -75.33K | $ -5.14M | $ -14.06M | $ -1.59M |
| Total Liabilities | $ 634.76K | $ 3.23M | $ 2.87M | $ 1.16M | $ 899.64K |
| Stockholders' Equity | $ 3.97M | $ -2.59M | $ 3.05M | $ 13.35M | $ 2.01M |
| Cash Flow | |||||
| Free Cash Flow | $ -6.87M | $ -8.42M | $ -8.92M | $ -6.72M | $ -2.71M |
| Operating Cash Flow | $ -6.57M | $ -8.27M | $ -8.92M | $ -6.61M | $ -2.71M |
| Investing Cash Flow | $ -300.00K | $ -147.24K | $ 0.00 | $ -106.46K | $ 100.92K |
| Financing Cash Flow | $ 10.44M | $ 3.65M | $ 200.00 | $ 18.85M | $ 4.45M |